Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies by Kirsten Craven | 0 CommentsAs therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.
Bioanalysis across modalities: Advancing confident decisions with modern LC‑MS strategies by Kirsten Craven | Biopharma, Blogs, PharmaAs therapeutic pipelines continue to diversify, bioanalysis is being asked to do more than ever before. From small molecules to complex biologics, today’s scientists must generate high‑quality, reliable data across a growing range of molecule types and workflows, often under increasing time pressure.